Medtronic
MDT· Manufacturing· Fiscal year ends in April
CEO pay in FY2026
Geoff Martha is the CEO of Medtronic and was paid $22.9M in FY2026 (Apr), up 8%.
PayNo stock prices for these years
Executives5
See all- 1Geoff MarthaChairman and Chief Executive OfficerFY2026
- 2Thierry PiétonEVP, Chief Financial OfficerFY2026
- 3Brett A. WallEVP & President, Neuroscience PortfolioFY2026
- 4Mike MarinaroEVP & President Medical Surgical Portfolio & AmericasFY2026
- 5Michelle QuinnEVP, General Counsel and SecretaryFY2026
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMedtronic paid its 5 named executives $52.0M in total in FY2026 (Apr). CEO Geoff Martha was paid $22.9M of that.
| Name | |||
|---|---|---|---|
| Geoff MarthaChairman and Chief Executive Officer | |||
| Thierry PiétonEVP, Chief Financial Officer | Not disclosed | ||
| Brett A. WallEVP & President, Neuroscience Portfolio | |||
| Mike MarinaroEVP & President Medical Surgical Portfolio & Americas | Not disclosed | Not disclosed | |
| Michelle QuinnEVP, General Counsel and Secretary | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers21
See allThe comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Geoff MarthaChair · 7 yr on the boardNot independentGrowth (Chair), Operations (Chair)—Paid as an executive
- Randall J. Hogan, IIIDirector · 11 yr on the boardIndependentAudit, Operations—Paid as an executive
- Gregory P. LewisDirector · 3 yr on the boardIndependentAudit (Chair), Growth—Paid as an executive
- John P. GroetelaarsDirector · 1 yr on the boardIndependentGrowth, Nominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2026).
Activity
No new filings about this company in the feed.
Filings35
See all| Current report | 8-K | Oct 19, 2026 | — |
| Proxy statement | DEF 14A | Aug 17, 2026 | FY2026 |
| Annual report | 10-K | Jun 18, 2026 | FY2026 |
| Current report | 8-K | Nov 3, 2025 | — |
| Current report | 8-K | Oct 21, 2025 | — |
| Proxy statement | DEF 14A | Aug 25, 2025 | FY2025 |